Phathom Pharmaceuticals (PHAT) Financials

$9.11

$0.06 (0.66%)

As on 04-Sep-2026 13:36EDT

Market cap

$743 Mln

Revenue (TTM)

$240 Mln

P/E Ratio

--

P/B Ratio

25.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	239.66	175.11	55.25	0.68	--	--
Cost of Revenue	40.93	22.60	7.97	0.17	0.62	0.52
Gross Profit	198.73	152.51	47.28	0.52	-0.62	-0.52
Operating Expenses	239.37	312.50	324.75	167.83	171.82	134.56
Operating Profit (EBIT)	-40.64	-159.99	-277.47	-167.31	-172.44	-135.08
Other Income	--	--	--	--	--	-2.02
Profit before Tax	-99.07	-221.25	-334.33	-201.59	-197.72	-143.88
Provision for Tax	--	--	--	41.78	25.28	4.21
Profit after Tax (Net Income)	-99.07	-221.25	-334.33	-201.59	-197.72	-143.88
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-197.72	-143.88

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-344.27	-438.17	-253.58	-72.76	-74.81	72.16
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	517.57	565.27	546.17	447.82	213.39	98.35
Current Liabilities	153.78	132.04	85.73	38.78	26.24	18.92
Total Liabilities	480.85	259.15	378.32	413.84	164.81	189.43

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	31.16	30.18	18.18	16.41	4.30	2.91
Current Assets	295.92	228.97	360.13	397.43	160.51	186.53
Total Assets	480.85	259.15	378.32	413.84	164.81	189.43
Total Debt*	167.11	211.80	201.91	139.03	97.07	91.34
Net Current Assets	142.14	96.93	274.41	358.65	134.28	167.61

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-166.78	-266.77	-137.58	-146.53	-148.46
Cash Flow from Investing Activities	--	-0.23	-0.14	-1.63	-1.04	-0.33
Cash from Financing Activities	--	-0.29	182.77	367.58	120.04	44.71
Net Cash Inflow / Outflow	--	--	--	--	--	-104.24

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.27	-3.00	-4.71	-3.93	-4.79	-3.81
Cash EPS ($)	--	-2.99	-4.69	-3.92	-4.77	-3.80
Adjusted Book Value ($)	--	--	--	--	--	1.91
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.26	-3.75	-2.68	-3.55	-3.93
Free Cash Flow per Share ($)	--	-2.26	-3.76	-2.71	-3.57	-3.94

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	159.15	-4,579.49	-455.44	-212.89	-70.74
ROE (%)	--	63.97	204.89	273.21	14,877.58	-108.01
ROA (%)	-24.08	-69.41	-84.41	-69.68	-111.63	-59.39
EBIT Margin (%)	-14.87	-87.45	-474.76	-23,405.28	--	--
Net Margin (%)	-41.34	-126.35	-605.09	-29,558.94	--	7,140.60
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	110.16	2.17	80.01	--	--	--
EBIT Growth (%)	86.16	41.62	-64.33	6.33	-24.31	-10.13
Net Profit Growth (%)	69.99	33.82	-65.84	-1.96	-37.42	-11.48
EPS Growth (%)	73.04	0.36	-0.20	0.18	-0.26	-0.01
Book Value Growth (%)	26.60	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.54	-1.73	-2.32	-2.34	-5.16
Price / Book Value	25.37	-2.79	-2.27	-6.44	-6.20	10.29
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.20	-8.57	-1.84	-1.42	-2.39	-4.77
Close Price ($)	10.85	16.59	8.12	9.13	11.22	19.67
High Price ($)	18.31	18.31	19.71	17.02	20.30	50.78
Low Price ($)	7.61	2.21	6.07	5.84	6.10	17.42
Market Cap ($ Cr)	742.67	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-0.48	-0.48	-0.80	-1.91	-1.30	1.27
Short term debt to equity ratio	0.00	0.00	0.00	-0.01	-0.01	0.01
Current Ratio	1.92	1.73	4.20	10.25	6.12	9.86
Quick Ratio	1.87	1.69	4.16	10.22	6.12	--
Interest Coverage	-0.56	-2.25	-3.64	-3.80	-6.24	-20.20

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	40.65	44.62	70.22	240.03	--	--
Asset Turnover	0.58	0.55	0.14	0.00	--	--
Receivable days	--	121.94	133.65	438.35	--	--
Inventory Days	--	70.52	101.15	1,321.02	--	-57.49
Payable days	--	125.18	529.30	24,712.33	4,461.65	7,687.78
Cash Conversion Cycle	--	67.28	-294.50	-22,952.96	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.